These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 18271870)
21. CEL-SCI offers South Africa a free license to use AIDS vaccine. AIDS Read; 2000 Jun; 10(6):340. PubMed ID: 10881364 [No Abstract] [Full Text] [Related]
22. HIV/AIDS vaccines: a need for new concepts? Girard MP; Bansal GP Int Rev Immunol; 2008; 27(6):447-71. PubMed ID: 19065351 [TBL] [Abstract][Full Text] [Related]
23. HIV vaccine research in Thailand: lessons learned. Pitisuttithum P Expert Rev Vaccines; 2008 Apr; 7(3):311-7. PubMed ID: 18393601 [TBL] [Abstract][Full Text] [Related]
27. Oral AIDS vaccine used in Thailand. AIDS Patient Care STDS; 2007 Nov; 21(11):894. PubMed ID: 18338436 [No Abstract] [Full Text] [Related]
28. A new era in HIV vaccine development. Lau CY; Velasco PP; Johnston MI Expert Rev Anti Infect Ther; 2007 Apr; 5(2):205-15. PubMed ID: 17402836 [TBL] [Abstract][Full Text] [Related]
30. [HIV genetic diversity and its consequences]. Roquebert B; Damond F; Brun-Vézinet F; Descamps D Pathol Biol (Paris); 2009 Mar; 57(2):142-8. PubMed ID: 18511216 [TBL] [Abstract][Full Text] [Related]
31. Modeling the potential public health impact of imperfect HIV vaccines. Blower S J Infect Dis; 2005 Oct; 192(8):1494-5; author reply 1495-6. PubMed ID: 16170769 [No Abstract] [Full Text] [Related]
32. AIDS vaccine efforts have followed long, bumpy road. AIDS Alert; 2001 May; 16(5):64-6, 54. PubMed ID: 11590782 [TBL] [Abstract][Full Text] [Related]
33. [HIV--vaccine study failures]. Winckler T Pharm Unserer Zeit; 2008; 37(1):71. PubMed ID: 18081049 [No Abstract] [Full Text] [Related]
34. [Therapeutic and preventive vaccine against HIV problems and the necessity to develop one]. García F Rev Enferm; 2005 Dec; 28(12):24-8. PubMed ID: 16459877 [TBL] [Abstract][Full Text] [Related]
35. Broadening inclusion of vulnerable populations in HIV vaccine trials. Lau CY; Cardinali M; Sato PA; Fix A; Flores J Expert Rev Vaccines; 2008 Mar; 7(2):259-68. PubMed ID: 18324894 [TBL] [Abstract][Full Text] [Related]
36. Tracking spending on vaccine, microbicide, and PrEP research and development. McEnery R IAVI Rep; 2009; 13(4):19. PubMed ID: 20229627 [No Abstract] [Full Text] [Related]
37. Cytokines as adjuvants for improving anti-HIV responses. Morrow MP; Weiner DB AIDS; 2008 Jan; 22(3):333-8. PubMed ID: 18195559 [No Abstract] [Full Text] [Related]
38. AIDS vaccine on test in China. Ojcius D Nat Rev Microbiol; 2005 Jan; 3(1):11. PubMed ID: 15635778 [No Abstract] [Full Text] [Related]
39. Combining DNA technologies and different modes of immunization for induction of humoral and cellular anti-HIV-1 immune responses. Bråve A; Hallengärd D; Malm M; Blazevic V; Rollman E; Stanescu I; Krohn K Vaccine; 2009 Jan; 27(2):184-6. PubMed ID: 18992294 [TBL] [Abstract][Full Text] [Related]
40. The failure of HIV vaccines: a new autovaccine may overcome some problems. Bocci V; Travagli V; Zanardi I Med Hypotheses; 2009 Jun; 72(6):662-4. PubMed ID: 19223126 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]